Changchun High-Tech Industries announced that the pediatric Gold cough granules, submitted by its holding subsidiary Changchun Jinsai Pharmaceutical Co., Ltd., in partnership with the holding subsidiary Jilin Huakang Pharmaceutical Co., Ltd., and Beijing Dongfang Yunjia Pharmaceutical Co., Ltd., have been approved for sale through the priority review and approval process by the National Medical Products Administration.
长春高新：合作产品小儿黄金止咳颗粒在境内获批上市
Changchun High-Tech Industries: The pediatric Gold cough granules have been approved for sale domestically.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated